Oncolytics Biotech Files Form 6-K
Ticker: ONCY · Form: 6-K · Filed: Nov 12, 2024 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | Nov 12, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory-update
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH INC (ONCY) filed a 6-K, standard reporting for foreign issuers.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on November 12, 2024, to report information for the month of November 2024. The company is a foreign private issuer based in Calgary, Alberta, Canada, and is subject to SEC Act of 1934. It is listed under SIC code 2834 for Pharmaceutical Preparations.
Why It Matters
This filing indicates that Oncolytics Biotech Inc. is providing updated information to the SEC, which is crucial for investors to stay informed about the company's regulatory compliance and operational status.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Registrant
- 20241112 (date) — Filing Date
- November 2024 (date) — Reporting Period
- Calgary, Alberta, Canada (location) — Company Headquarters
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is submitted to the SEC to provide information that the registrant makes or is required to make public pursuant to the laws of its home country, or that is made or is required to be made public to security holders, or that is distributed or is required to be distributed to security holders.
What is the SIC code for Oncolytics Biotech Inc.?
The Standard Industrial Classification (SIC) code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
What is the SEC file number for Oncolytics Biotech Inc.?
The SEC file number for Oncolytics Biotech Inc. is 001-38512.
Does Oncolytics Biotech Inc. file an annual report under Form 20-F or 40-F?
Oncolytics Biotech Inc. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2024-11-12 08:19:10
Filing Documents
- form6kq3-2024dateannouncem.htm (6-K) — 18KB
- oncyq32024callpr.htm (EX-99.1) — 11KB
- 0001129928-24-000066.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date November 12, 2024 Kirk Look Chief Financial Officer